Volume 136, Issue 5, Pages (May 2009)

Slides:



Advertisements
Similar presentations
Volume 57, Issue 3, Pages (March 2000)
Advertisements

Volume 133, Issue 1, Pages (July 2007)
Volume 145, Issue 4, Pages e2 (October 2013)
Volume 145, Issue 2, Pages (August 2013)
Volume 142, Issue 4, Pages e3 (April 2012)
Volume 132, Issue 5, Pages (May 2007)
Volume 133, Issue 2, Pages (August 2007)
Volume 140, Issue 2, Pages e2 (February 2011)
Volume 134, Issue 4, Pages (April 2008)
Foxf2 in Intestinal Fibroblasts Reduces Numbers of Lgr5+ Stem Cells and Adenoma Formation by Inhibiting Wnt Signaling   Ali Moussavi Nik, Azadeh Reyahi,
Volume 118, Issue 4, Pages (April 2000)
Volume 133, Issue 5, Pages (November 2007)
Volume 57, Issue 3, Pages (March 2000)
Volume 133, Issue 1, Pages (July 2007)
Volume 129, Issue 3, Pages (September 2005)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 142, Issue 4, Pages (April 2012)
Volume 138, Issue 3, Pages e2 (March 2010)
Volume 137, Issue 4, Pages e3 (October 2009)
Richard T. Ethridge, Mark R. Hellmich, Raymond N. DuBois, B.Mark Evers 
Volume 143, Issue 4, Pages e9 (October 2012)
Volume 133, Issue 6, Pages (December 2007)
Prolyl Hydroxylase-3 Is Down-regulated in Colorectal Cancer Cells and Inhibits IKKβ Independent of Hydroxylase Activity  Jing Xue, Xuebing Li, Shi Jiao,
Volume 7, Issue 6, Pages (December 1997)
Teruaki Fujishita, Masahiro Aoki, Makoto M. Taketo  Gastroenterology 
Volume 141, Issue 6, Pages (December 2011)
Volume 145, Issue 4, Pages e2 (October 2013)
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 142, Issue 3, Pages (March 2012)
Volume 138, Issue 2, Pages (February 2010)
Volume 134, Issue 1, Pages (January 2008)
John F. Öhd, Katarina Wikström, Anita Sjölander  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Volume 122, Issue 5, Pages (May 2002)
Volume 136, Issue 5, Pages (May 2009)
Volume 136, Issue 2, Pages (February 2009)
Volume 133, Issue 5, Pages (November 2007)
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Shrikant Anant, Courtney W. Houchen  Gastroenterology 
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 142, Issue 3, Pages e2 (March 2012)
Volume 131, Issue 4, Pages (October 2006)
This Month in Gastroenterology
Volume 145, Issue 2, Pages (August 2013)
Volume 140, Issue 3, Pages (March 2011)
Volume 132, Issue 3, Pages (March 2007)
Volume 142, Issue 7, Pages e2 (June 2012)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 135, Issue 3, Pages e3 (September 2008)
Volume 131, Issue 6, Pages (December 2006)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 129, Issue 5, Pages (November 2005)
Volume 138, Issue 1, Pages e5 (January 2010)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 139, Issue 6, Pages (December 2010)
Volume 138, Issue 7, Pages e1 (June 2010)
TRF2 Protects Human Telomeres from End-to-End Fusions
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
A Novel Role of Transforming Growth Factor β1 in Transcriptional Repression of Human Cholesterol 7α-Hydroxylase Gene  Tiangang Li, John Y.L. Chiang  Gastroenterology 
Volume 138, Issue 4, Pages (April 2010)
Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for Carcinogenesis  Norihisa Ishimura, Steven F. Bronk, Gregory.
Urtzi Garaigorta, Francis V. Chisari  Cell Host & Microbe 
Volume 131, Issue 2, Pages (August 2006)
Volume 128, Issue 7, Pages (June 2005)
Volume 129, Issue 2, Pages (April 2007)
This month in Gastroenterology
Volume 123, Issue 3, Pages (September 2002)
Volume 2, Issue 4, Pages (October 2002)
Foxf2 in Intestinal Fibroblasts Reduces Numbers of Lgr5+ Stem Cells and Adenoma Formation by Inhibiting Wnt Signaling   Ali Moussavi Nik, Azadeh Reyahi,
Presentation transcript:

Volume 136, Issue 5, Pages 1669-1679 (May 2009) The mRNA Binding Proteins HuR and Tristetraprolin Regulate Cyclooxygenase 2 Expression During Colon Carcinogenesis  Lisa E. Young, Sandhya Sanduja, Kristi Bemis–Standoli, Edsel A. Pena, Robert L. Price, Dan A. Dixon  Gastroenterology  Volume 136, Issue 5, Pages 1669-1679 (May 2009) DOI: 10.1053/j.gastro.2009.01.010 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Immunohistochemical detection of HuR, TTP, and COX-2 expression in colon tissue. Representative serial sections from tissue samples of normal colon epithelium (left), tubular adenoma (center), and adenocarcinoma (stage T3; right) were examined for HuR, TTP, or COX-2 expression. (A) Nuclear HuR localization is observed in normal epithelium, and elevated HuR expression localized to the nucleus and cytoplasm occurs in adenoma and adenocarcinoma. (B) Cytoplasmic TTP expression is observed in normal epithelium, whereas TTP immunostaining of tumor tissue is low or negative. (C) COX-2 expression is negative in normal epithelium and elevated in adenoma and adenocarcinoma. Original magnification, 200×. Gastroenterology 2009 136, 1669-1679DOI: (10.1053/j.gastro.2009.01.010) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Immunoreactivity score (IRS) distribution of HuR (A) and TTP (B) protein expression in normal colon tissue, adenomas, and adenocarcinomas. Scores were calculated and plotted as percentage of samples displaying a low IRS from 0 to 6 (grey bars) and high IRS from 7–12 (black bars) for each tissue type. Gastroenterology 2009 136, 1669-1679DOI: (10.1053/j.gastro.2009.01.010) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 HuR, TTP, and COX-2 mRNA expression are altered in colorectal cancer. Human colon tissue (N1–N5, normal; T1–T41, tumors) gene expression panels were analyzed for HuR (A), TTP (B), and COX-2 (C) expression by qPCR and standardized using β-actin. The data are represented as fold change in mRNA expression normalized to N1 for HuR, TTP, or COX-2. Gastroenterology 2009 136, 1669-1679DOI: (10.1053/j.gastro.2009.01.010) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 HuR and TTP expression in colon cancer cell lines. (A) Immunofluorescent detection of HuR, shown in green, in LoVo, HCA7, and Moser colon cancer cell lines; nuclei are shown in blue. Moser cells treated without primary antibody are shown. (B and C) Western blot analysis of HuR, COX-2, and TTP expression in LoVo, HCA7, Moser, HT29, SKCO1, and CaCo2 cells. Total protein extracts were analyzed by SDS-PAGE and probed for HuR, COX-2, or TTP. β-actin served as a loading control. COS7 cells transfected with a human TTP expression vector served as a positive control for TTP. Gastroenterology 2009 136, 1669-1679DOI: (10.1053/j.gastro.2009.01.010) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 Regulation of COX-2 by HuR and TTP. (A) COX-2 protein (top panel) and mRNA (bottom panel) expression in HeLa-Tet-OFF/HuR-Flag cells grown in the presence or absence of Dox (2 μg/mL) to induce HuR-Flag. After 48 hours of growth, cells were treated with IL-1β (10 ng/mL) or left untreated for 24 hours. (B) Identical treatments were performed using HeLa-Tet-OFF/TTP-Flag cells. COX-2, Flag-TTP, Flag-HuR, and β-actin were detected by Western blot. COX-2 mRNA was examined by qPCR and normalized to 18S rRNA levels. Values shown are based on COX-2 levels from uninduced cells (+ Dox). (C) TTP antagonizes the ability of HuR overexpression to promote COX-2 expression. Expression constructs containing full-length COX-2 (COX-2+3′UTR), Flag-tagged HuR, and Flag-tagged TTP were transfected into COS7 cells. The amount of COX-2 and HuR constructs was kept constant at 0.2 and 0.4 μg, respectively. Increasing amounts of TTP construct were transfected using empty vector to keep total DNA transfected at 1 μg. COX-2, Flag-TTP, Flag-HuR, and β-actin were detected by Western blot. Gastroenterology 2009 136, 1669-1679DOI: (10.1053/j.gastro.2009.01.010) Copyright © 2009 AGA Institute Terms and Conditions

Figure 6 TTP expression in colon cancer cells inhibits COX-2 and attenuates cell growth. HCA7 (A) and Moser (B) cells infected with AdGFP or AdGFP/TTP-Flag virus at the indicated MOI for 48 hours were examined for TTP and COX-2 expression by Western blotting. β-actin was used as a loading control. (C) Phase contrast microscopy of HCA7 and Moser cells after 48 hours of infection with AdGFP or AdGFP/TTP-Flag virus using MOIs of 100 and 20, respectively. Uninfected cells are shown. Original magnification, 100×. Gastroenterology 2009 136, 1669-1679DOI: (10.1053/j.gastro.2009.01.010) Copyright © 2009 AGA Institute Terms and Conditions